Trial reportNutrients2026
Low-Protein Diet Supplemented with Ketoanalogues and Progression of Chronic Kidney Disease in Diabetic Patients: A Multicenter Randomized Controlled Trial.
Ramón Paniagua, Marcela Ávila-Díaz, Julia Nava, Renata Romero-Salas, Juan Carlos H Hernández-Rivera, Oliva Mejía-Rodríguez, Giorgina B Picolli, Mexican Nephrology Collaborative Study Group
Abstract readRandomized Controlled TrialMulticenter Study
In one paragraphTrial report in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Ramón PaniaguaUnidad de Investigación Médica en Enfermedades Nefrológicas, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0003-3577-9707 Marcela Ávila-DíazUnidad de Investigación Médica en Enfermedades Nefrológicas, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0001-8855-9682 Julia NavaCentro de Atención Nutricional Fresenius Kabi, Ciudad de México 11590, Mexico.
Renata Romero-SalasUnidad de Investigación Médica en Enfermedades Nefrológicas, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0003-4312-1593 Juan Carlos H Hernández-RiveraUnidad de Investigación Médica en Enfermedades Nefrológicas, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.
Oliva Mejía-RodríguezHospital General de Zona N° 83, Instituto Mexicano del Seguro Social, Morelia 58070, Mexico.ORCID 0000-0001-7261-6419 Giorgina B PicolliNéphrologie, Centre Hospitalier Le Mans, 194 Avenue Rubillard, 72037 Le Mans, France.
Mexican Nephrology Collaborative Study Group
Funding
Fresenius Kabi (United States) R-2019-05-08
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 2Diabetic NephropathiesDietary SupplementsDiet, Protein-RestrictedKeto AcidsRenal Insufficiency, ChronicAgedDisease ProgressionFemaleGlomerular Filtration RateHumansMaleMiddle AgedNutritional StatusKeto Acidschronic kidney diseasechronic kidney disease progressionlow-protein dietstype 2 diabetes mellitusα-Ketoanalogues
Identifiers
PMID42654210
PMCPMC13516023
What OpenQuestion holds
Textmetadata
Read underepoch 390